Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium.
Saved in:
| Title: | Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium. |
|---|---|
| Authors: | Kanwal F; Department of Medicine and the Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.; Houston VA Health Services Research and Development Service Center of Excellence, Michael E. DeBakey VA Medical Center, Houston, Texas, USA., Feng Z; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA., Hoshida Y; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA., Chhatwal J; Center for Health Technology Assessment, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA., Wong VW; Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China., Ioannou GN; Division of Gastroenterology and Hepatology, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA., Nahon P; AP-HP, Hôpitaux Universitaires Paris Seine Saint-Denis, Liver Unit, Bobigny, France.; Department of Hepatology, Université Sorbonne Paris Nord, Bobigny, France.; Inserm, UMR-1138 'Functional Genomics of Solid Tumors,' Centre de recherche des Cordeliers, Université de Paris, Paris, France., Lotter W; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA., Ning J; Department of Biostatistics, MD Anderson Cancer Center, Houston, Texas, USA., Taouli B; Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA., Marquez G; Division of Cancer Prevention, Cancer Biomarker Branch, National Cancer Institute, Rockville, Maryland, USA., Fu SW; Division of Cancer Prevention, Cancer Biomarker Branch, National Cancer Institute, Rockville, Maryland, USA., Singal AG; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. |
| Source: | Hepatology (Baltimore, Md.) [Hepatology] 2026 Apr 20. Date of Electronic Publication: 2026 Apr 20. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wolters Kluwer Health, Inc Country of Publication: United States NLM ID: 8302946 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1527-3350 (Electronic) Linking ISSN: 02709139 NLM ISO Abbreviation: Hepatology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 42008824 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Kanwal+F%22">Kanwal F</searchLink>; Department of Medicine and the Institute of Clinical and Translational Research, Baylor College of Medicine, Houston, Texas, USA.; Houston VA Health Services Research and Development Service Center of Excellence, Michael E. DeBakey VA Medical Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Feng+Z%22">Feng Z</searchLink>; Public Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Hoshida+Y%22">Hoshida Y</searchLink>; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Chhatwal+J%22">Chhatwal J</searchLink>; Center for Health Technology Assessment, Mass General Brigham, Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Wong+VW%22">Wong VW</searchLink>; Medical Data Analytics Center, Department of Medicine and Therapeutics, The Chinese University of Hong Kong, Hong Kong, China.<br /><searchLink fieldCode="AU" term="%22Ioannou+GN%22">Ioannou GN</searchLink>; Division of Gastroenterology and Hepatology, Veterans Affairs Puget Sound Health Care System and University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Nahon+P%22">Nahon P</searchLink>; AP-HP, Hôpitaux Universitaires Paris Seine Saint-Denis, Liver Unit, Bobigny, France.; Department of Hepatology, Université Sorbonne Paris Nord, Bobigny, France.; Inserm, UMR-1138 'Functional Genomics of Solid Tumors,' Centre de recherche des Cordeliers, Université de Paris, Paris, France.<br /><searchLink fieldCode="AU" term="%22Lotter+W%22">Lotter W</searchLink>; Department of Data Science, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Ning+J%22">Ning J</searchLink>; Department of Biostatistics, MD Anderson Cancer Center, Houston, Texas, USA.<br /><searchLink fieldCode="AU" term="%22Taouli+B%22">Taouli B</searchLink>; Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, New York, USA.<br /><searchLink fieldCode="AU" term="%22Marquez+G%22">Marquez G</searchLink>; Division of Cancer Prevention, Cancer Biomarker Branch, National Cancer Institute, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Fu+SW%22">Fu SW</searchLink>; Division of Cancer Prevention, Cancer Biomarker Branch, National Cancer Institute, Rockville, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Singal+AG%22">Singal AG</searchLink>; Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, Texas, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%228302946%22">Hepatology (Baltimore, Md.)</searchLink> [Hepatology] 2026 Apr 20. <i>Date of Electronic Publication: </i>2026 Apr 20. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wolters+Kluwer+Health%2C+Inc%22">Wolters Kluwer Health, Inc </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>8302946 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1527-3350 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2202709139%22">02709139 </searchLink><i>NLM ISO Abbreviation: </i>Hepatology <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=42008824 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1097/HEP.0000000000001745 Languages: – Code: eng Text: English Titles: – TitleFull: Development and validation of risk stratification models for hepatocellular cancer: A framework from the translational liver cancer consortium. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Kanwal F – PersonEntity: Name: NameFull: Feng Z – PersonEntity: Name: NameFull: Hoshida Y – PersonEntity: Name: NameFull: Chhatwal J – PersonEntity: Name: NameFull: Wong VW – PersonEntity: Name: NameFull: Ioannou GN – PersonEntity: Name: NameFull: Nahon P – PersonEntity: Name: NameFull: Lotter W – PersonEntity: Name: NameFull: Ning J – PersonEntity: Name: NameFull: Taouli B – PersonEntity: Name: NameFull: Marquez G – PersonEntity: Name: NameFull: Fu SW – PersonEntity: Name: NameFull: Singal AG IsPartOfRelationships: – BibEntity: Dates: – D: 20 M: 04 Text: 2026 Apr 20 Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1527-3350 Titles: – TitleFull: Hepatology (Baltimore, Md.) Type: main |
| ResultId | 1 |